The Nucleic Acid Therapeutics Initiative (NATi), hosted by A*STAR, is Singapore's national platform dedicated to advancing RNA-based medicines and revolutionizing drug and vaccine development. NATi's mission is to establish Singapore as a globally recognized hub of excellence in nucleic acid therapeutics research, clinical translation, and commercialization.

We seek a highly innovative and results-driven scientific leader with deep expertise spanning multiple RNA modalities to establish the analytical development processes. This role is instrumental in establishing and executing phase-appropriate analytical strategies for raw materials (e.g., novel lipids, targeting ligands, pDNA), drug substances (DS) spanning mRNA and synthetic oligonucleotides (e.g., ASO, siRNA, gRNA), and drug products (DP) (e.g., conjugated oligonucleotides). The successful candidate will establish robust, scalable, and phase-appropriate analytical workflows ...